Success Metrics

Clinical Success Rate
84.8%

Based on 39 completed trials

Completion Rate
85%(39/46)
Active Trials
5(8%)
Results Posted
38%(15 trials)
Terminated
7(11%)

Phase Distribution

Ph not_applicable
25
40%
Ph early_phase_1
4
6%
Ph phase_1
17
27%
Ph phase_3
7
11%
Ph phase_4
3
5%
Ph phase_2
6
10%

Phase Distribution

21

Early Stage

6

Mid Stage

10

Late Stage

Phase Distribution62 total trials
Early Phase 1First-in-human
4(6.5%)
Phase 1Safety & dosage
17(27.4%)
Phase 2Efficacy & side effects
6(9.7%)
Phase 3Large-scale testing
7(11.3%)
Phase 4Post-market surveillance
3(4.8%)
N/ANon-phased studies
25(40.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

39 of 48 finished

Non-Completion Rate

18.8%

9 ended early

Currently Active

5

trials recruiting

Total Trials

63

all time

Status Distribution
Active(7)
Completed(39)
Terminated(9)
Other(8)

Detailed Status

Completed39
Terminated7
unknown7
Recruiting3
Active, not recruiting2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
63
Active
5
Success Rate
84.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (6.5%)
Phase 117 (27.4%)
Phase 26 (9.7%)
Phase 37 (11.3%)
Phase 43 (4.8%)
N/A25 (40.3%)

Trials by Status

recruiting35%
terminated711%
suspended12%
active_not_recruiting23%
enrolling_by_invitation12%
unknown711%
completed3962%
withdrawn23%
not_yet_recruiting12%

Recent Activity

Clinical Trials (63)

Showing 20 of 63 trialsScroll for more
NCT07633509Not Applicable

The COMBINE-AF Trial

Not Yet Recruiting
NCT06819189Phase 1

Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors

Recruiting
NCT00875069Phase 3

Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial

Completed
NCT00961792Not Applicable

Chicago Social Drinking Project

Active Not Recruiting
NCT03085004Phase 3

CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Terminated
NCT06065657Phase 2

Effect of Nutritional Ketosis on Alcohol Metabolism

Recruiting
NCT00682318Not Applicable

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

Active Not Recruiting
NCT06143059Phase 3

The Effects of Sex Hormones and Alcohol on Sleep

Suspended
NCT01898221Phase 3

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Completed
NCT06091189Early Phase 1

Internalized Stress in Relation to Alcohol Consumption

Terminated
NCT03964350Early Phase 1

Behavior Brain Responses

Completed
NCT00661141Phase 2

Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism

Completed
NCT06559878Not Applicable

Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans

Enrolling By Invitation
NCT04925076Not Applicable

Characterizing the Effects of Family History of Alcoholism on Alcohol Analgesia

Completed
NCT03083184Phase 3

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Recruiting
NCT05130619Not Applicable

Human Auto-ethanol Formation and Acetate Signaling

Unknown
NCT00990275Not Applicable

Alcohol Exposure and Airway Hyperresponsiveness

Completed
NCT04019093Not Applicable

Acute Effects of Alcohol Use on Chronic Orofacial Pain

Completed
NCT05670184Phase 1

The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality

Unknown
NCT03165942Phase 1

Neuroendocrine Response to Oral Alcohol Administration

Completed

Drug Details

Intervention Type
DRUG
Total Trials
63